Comparison
3 Methylglutaconic Aciduria Type 2 C0574083 vs 17q12 Recurrent Deletion Syndrome C6011081
Clinical comparison between 3 Methylglutaconic Aciduria Type 2 and 17q12 Recurrent Deletion Syndrome for differential diagnosis and treatment planning.
3 Methylglutaconic Aciduria Type 2 C0574083
Also called Barth syndrome, this genetic condition primarily affects males and impairs mitochondrial function. It causes heart muscle weakness, muscle weakness, and recurrent infections. Treatment includes cardiac care, infection prevention, and supportive therapies.
17q12 Recurrent Deletion Syndrome C6011081
A genetic condition from deletion on chromosome 17. Can involve developmental delays, neurological features, and potential kidney involvement. Management requires regular monitoring and supportive therapies.
6 comparison axes
Onset
3 Methylglutaconic Aciduria Type 2 C0574083
0-5
17q12 Recurrent Deletion Syndrome C6011081
0-null
Onset patterns differ
Severity
3 Methylglutaconic Aciduria Type 2 C0574083
severe
17q12 Recurrent Deletion Syndrome C6011081
moderate
Different severity levels
Chronic
3 Methylglutaconic Aciduria Type 2 C0574083
Chronic
17q12 Recurrent Deletion Syndrome C6011081
Chronic
Differing course
Communicable
3 Methylglutaconic Aciduria Type 2 C0574083
No
17q12 Recurrent Deletion Syndrome C6011081
No
Different transmission
Body System
3 Methylglutaconic Aciduria Type 2 C0574083
metabolic
17q12 Recurrent Deletion Syndrome C6011081
congenital
Same/different system
Category
3 Methylglutaconic Aciduria Type 2 C0574083
metabolic
17q12 Recurrent Deletion Syndrome C6011081
genetic
Different category
Bottom line
3-methylglutaconic-aciduria-type-2-C0574083 and 17q12-recurrent-deletion-syndrome-C6011081 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Methylglutaconic Aciduria Type 2 C0574083 | 17q12 Recurrent Deletion Syndrome C6011081 | Discriminating power |
|---|---|---|---|
| Typical clinical focus | Cardiomyopathy, skeletal-muscle weakness, and recurrent infections, mainly in males. | Developmental delay, neurologic features, and possible kidney involvement in either sex. | High |
| Genetic mechanism | Mitochondrial dysfunction from an X-linked genetic condition. | Recurrent deletion on chromosome 17q12. | High |
| Organ-system emphasis | Heart, muscle, and infection susceptibility dominate the supplied description. | Neurodevelopment and possible renal involvement are emphasized. | Moderate |
When to favor each condition
Choose 3 Methylglutaconic Aciduria Type 2 C0574083 when
A male child has cardiomyopathy with muscle weakness or recurrent infections.
This pattern matches the supplied Barth syndrome description better than 17q12 deletion.
High
Metabolic evaluation suggests 3-methylglutaconic aciduria.
The named biochemical abnormality points toward the left condition, but cutoffs are not supplied.
Moderate
Family history suggests X-linked disease affecting males.
That inheritance pattern favors Barth syndrome over a chromosomal deletion.
Moderate
Choose 17q12 Recurrent Deletion Syndrome C6011081 when
Developmental delay occurs with neurologic features or suspected kidney anomalies.
These features align with the supplied 17q12 deletion description.
High
A person of either sex has a congenital syndrome without dominant cardiomyopathy.
17q12 deletion is not described as primarily affecting males or heart muscle.
Moderate
Chromosomal testing is being considered for unexplained congenital findings.
A recurrent chromosomal deletion is assessed differently from a mitochondrial disorder.
Moderate
How key tests differ
| Test | 3 Methylglutaconic Aciduria Type 2 C0574083 | 17q12 Recurrent Deletion Syndrome C6011081 | Interpretation |
|---|---|---|---|
| Urine organic-acid analysis | May support 3-methylglutaconic aciduria; no cutoff is established here. | No characteristic organic-acid pattern is supplied. | An abnormal result is not itself a diagnosis and needs clinician correlation. |
| Genetic testing | Targets the Barth-associated genetic cause after specialist selection. | Chromosomal microarray or equivalent can detect a 17q12 deletion. | Confirmatory genetics distinguishes the conditions; test choice requires clinical judgment. |
| Organ-directed evaluation | Cardiac assessment and infection evaluation are central. | Developmental assessment and kidney monitoring may be appropriate. | Testing should follow the suspected organ involvement rather than a fixed panel. |
Prognosis comparison
3 Methylglutaconic Aciduria Type 2 C0574083
- Outcome
- Often requires long-term cardiac, infection-prevention, and supportive care; survival figures are not supplied.
- Factors
- Degree of cardiomyopathy, muscle weakness, infections, and response to supportive care.
17q12 Recurrent Deletion Syndrome C6011081
- Outcome
- Variable congenital course; developmental and possible kidney involvement guide needs. Exact prognosis is not established.
- Factors
- Extent of developmental, neurologic, and renal findings.
Time frame: Both are chronic; onset information is early childhood for the left and incompletely specified for the right.
Early recognition, organ involvement, supportive therapies, and access to specialist care.
Complications comparison
| Complication | Presentation |
|---|---|
| Major organ complication | Heart-muscle weakness may cause serious cardiac complications. Kidney involvement is possible but not inevitable from the supplied data. Frequency and severity are not established here. |
| Infection or neurologic burden | Recurrent infections are described and may require prevention. Neurologic and developmental complications may require support. Neither complication profile should be assumed complete. |
| Functional limitation | Muscle weakness can limit strength and endurance. Developmental delay can affect learning and adaptive skills. Individual impact varies and needs clinical assessment. |
Patient education highlights
- HighDifferent diagnoses
These are distinct genetic conditions; a test abnormality or suspicion requires specialist confirmation.
- HighMonitoring
Barth syndrome emphasizes heart and infection care; 17q12 deletion emphasizes development and possible kidney follow-up.
- MediumTransmission
Neither condition is communicable. Inheritance counseling should be individualized.